Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Paul J Newey"'
Autor:
Kate E Lines, Mahsa Javid, Anita A C Reed, Gerard V Walls, Mark Stevenson, Michelle Simon, Kreepa G Kooblall, Sian E Piret, Paul T Christie, Paul J Newey, Ann-Marie Mallon, Rajesh V Thakker
Publikováno v:
Endocrine Connections, Vol 9, Iss 5, Pp 426-437 (2020)
Multiple endocrine neoplasia type 1 (MEN1), an autosomal domina nt disorder caused by MEN1 germline mutations, is characterised by parathyroid, pancreati c and pituitary tumours. MEN1 mutations also cause familial isolated primary hyperparathyroi dis
Externí odkaz:
https://doaj.org/article/a2653ed4f925427ab63aff57abcabec7
Publikováno v:
Endocrine Connections, Vol 6, Iss 8, Pp 580-588 (2007)
Purpose: High serum prolactin concentrations have been associated with adverse health outcomes in some but not all studies. This study aimed to examine the morbidity and all-cause mortality associated with hyperprolactinaemia. Methods: A population-
Externí odkaz:
https://doaj.org/article/becb78689a7b450091dda29a9863f587
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year. Objective We planned to provide a current estimate of the incidence and prevalence of PHPT in a commun
Publikováno v:
Journal of Molecular Endocrinology. 70
The prolactin receptor (PRLR) signals predominantly through the JAK2-STAT5 pathway regulating multiple physiological functions relating to fertility, lactation, and metabolism. However, the molecular pathology and role of PRLR mutations and signallin
Autor:
Paul J. Newey
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 50:663-681
Primary hyperparathyroidism (PHPT) is a commonly encountered clinical problem and occurs as part of an inherited disorder in ∼10% of patients. Several features may alert the clinician to the possibility of a hereditary PHPT disorder (eg, young age
Autor:
Paul J. Newey
Publikováno v:
Medicine. 49:539-543
Multiple endocrine neoplasia (MEN) describes the occurrence of tumours affecting two or more endocrine glands in one patient. Two main forms are recognized: MEN type 1 (MEN1) and type 2 (MEN2). MEN1 is characterized by the combined occurrence of para
Autor:
Enrique Soto-Pedre, Paul J Newey, Sundararajan Srinivasan, Moneeza K Siddiqui, Colin N A Palmer, Graham P Leese
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(12)
Context A hypothesis-free genetic association analysis has not been reported for patients with primary hyperparathyroidism (PHPT). Objective We aimed to investigate genetic associations with PHPT using both genome-wide association study (GWAS) and ca
Autor:
Anita A C Reed, Mahsa Javid, Mark Stevenson, Paul T. Christie, Rajesh V. Thakker, Paul J. Newey, Michelle Simon, Ann-Marie Mallon, Sian E. Piret, Kate E Lines, Gerard V Walls, Kreepa Kooblall
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 9, Iss 5, Pp 426-437 (2020)
Endocrine Connections, Vol 9, Iss 5, Pp 426-437 (2020)
Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder caused by MEN1 germline mutations, is characterised by parathyroid, pancreatic and pituitary tumours. MEN1 mutations also cause familial isolated primary hyperparathyroidism (
Publikováno v:
Clinical endocrinologyREFERENCES. 97(4)
Disorders of calcium homeostasis are the most frequent metabolic bone and mineral disease encountered by endocrinologists. These disorders usually manifest as primary hyperparathyroidism (PHPT) or hypoparathyroidism (HP), which have a monogenic aetio
Autor:
Paul J Newey, John Newell-Price
Publikováno v:
Journal of the Endocrine Society
Clinical practice guidelines for patients with multiple endocrine neoplasia type 1 (MEN1) recommend a variety of surveillance options. Given progress over the past decade in this area, it is timely to evaluate their ongoing utility. MEN1 is character